Francesco Trotta

Dr. Francesco Trotta

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2013 in Vaccine
Verified
Journal Article
Closed access
LWLeonoor Wijnans
Leonoor Wijnans
CLCoralie Lecomte
Coralie Lecomte
CVCorinne de Vries
Corinne de Vries
DWDaniel Weibel
Daniel Weibel
CSCormac Sammon
Cormac Sammon
MSMiriam C.J.M. Sturkenboom
Miriam C.J.M. Sturkenboom

1 December 2016 in Vaccine
Verified
Journal Article
Open access
MDMalini DeSilva
Malini DeSilva
FMFlor M. Munoz
Flor M. Munoz
MMMark McMillan
Mark McMillan
AKAlison Tse Kawai
Alison Tse Kawai
HMHelen Marshall
Helen Marshall
EKElyse O. Kharbanda
Elyse O. Kharbanda

1 December 2016 in Vaccine
Verified
Journal Article
Closed access
CBCaterina Bonetto
Caterina Bonetto
FTFrancesco Trotta
Francesco Trotta
PFPatrizia Felicetti
Patrizia Felicetti
GAGraciela S. Alarcón
Graciela S. Alarcón
CSCarmela Santuccio
Carmela Santuccio
JBJan Bonhoeffer
Jan Bonhoeffer

1 November 2006 in International Clinical Psychopharmacology
Verified
Journal Article
Closed access
AAAlessandro Assisi
Alessandro Assisi
RBRita Banzi
Rita Banzi
CBCarmela Buonocore
Carmela Buonocore
FCFilippo Capasso
Filippo Capasso
VMValeria Di Muzio
Valeria Di Muzio
SGSilvio Garattini
Silvio Garattini
Epidemiological and experimental studies have indicated that consumption of more n-3 long-chain polyunsaturated fatty acids may reduce the risk for a variety of diseases, including cardiovascular, neurological and immunological disorders, diabetes and cancer. This article focuses on the role of marine n-3 long-chain polyunsaturated fatty acids in brain functions, including the development of the central nervous system and neurological disorders. An overview of the major animal studies and clinical trials is provided here, focusing on fatty acid supplementation during pregnancy and infancy, and prevention and management of Alzheimer's disease, schizophrenia, depression and attention deficit hyperactive disorder. Although an optimal balance in n-3/n-6 long-chain polyunsaturated fatty acid ratio is important for proper neurodevelopment and cognitive functions, results from randomized controlled trials are controversial and do not confirm any useful effect of supplementation on development of preterm and term infants. The relationship between fatty acid status and mental disorders is confirmed by reduced levels of n-3 long-chain polyunsaturated fatty acids in erythrocyte membranes of patients with central nervous system disorders. Nevertheless, there are very little data supporting the use of fish oil in those patients. The only way to verify whether n-3 long-chain polyunsaturated fatty acids are a potential therapeutic option in the management and prevention of mental disorders is to conduct a large definitive randomized controlled trials similar to those required for the licensing of any new pharmacological treatment.

26 July 2003 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
GCGiuseppe Campiani
Giuseppe Campiani
Stefania ButiniStefania Butini
Stefania Butini
FTFrancesco Trotta
Francesco Trotta
CFCaterina Fattorusso
Caterina Fattorusso
BCBruno Catalanotti
Bruno Catalanotti
TMTiziana Mennini£
Tiziana Mennini£

15 December 2008 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
Stefania ButiniStefania Butini
Stefania Butini
Sandra GemmaSandra Gemma
Sandra Gemma
GCGiuseppe Campiani
Giuseppe Campiani
SFSilvia Franceschini
Silvia Franceschini
FTFrancesco Trotta
Francesco Trotta
CFCaterina Fattorusso
Caterina Fattorusso